Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PAT complex subunit Asterix (encoded by WDR83OS) is a 106-amino acid chaperone protein that partners with CCDC47 to form the PAT complex, which facilitates the correct folding and ER membrane integration of multi-pass transmembrane proteins. This function is critical for cellular proteostasis, especially in handling complex membrane proteins. Loss-of-function variants in WDR83OS are associated with a distinct neurodevelopmental disorder characterized by intellectual disability, facial dysmorphism, pruritus, and elevated bile acids, but with relatively normal bilirubin and mild or absent liver enzyme abnormalities. The gene is not known to be a direct therapeutic target (no known drugs interact with it), but is of interest for its basic cellular role and involvement in rare genetic disease phenotypes[1][2][3][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PAT complex subunit Asterix (WDR83OS).